INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,196,609 | -22.5% | 37,873 | +0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,543,818 | +32.4% | 37,871 | +21.0% | 0.00% | 0.0% |
| Q1 2023 | $1,166,206 | -38.3% | 31,299 | -42.2% | 0.00% | 0.0% |
| Q4 2022 | $1,888,903 | +171.1% | 54,145 | +117.8% | 0.00% | 0.0% |
| Q3 2022 | $696,696 | +8.2% | 24,862 | +99.9% | 0.00% | – |
| Q2 2022 | $644,000 | -28.6% | 12,437 | +0.1% | 0.00% | – |
| Q1 2022 | $902,000 | -97.2% | 12,420 | -95.4% | 0.00% | -100.0% |
| Q4 2021 | $32,044,000 | -14.0% | 271,001 | -2.5% | 0.01% | -18.8% |
| Q3 2021 | $37,275,000 | -9.0% | 277,827 | +9.8% | 0.02% | -11.1% |
| Q2 2021 | $40,973,000 | +1331.6% | 253,097 | +609.8% | 0.02% | +1700.0% |
| Q1 2021 | $2,862,000 | – | 35,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |